SORAFENIB
Generic: SORAFENIB
Yabao Pharmaceutical Co.Manufacturer
ORALRoute
SORAFENIBActive Substance
2022-11-09Original Approval
SORAFENIB is FDA application ANDA209050, sponsored by YABAO PHARM. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
454 reports
2
DIARRHOEA
450 reports
3
FATIGUE
300 reports
4
ANAEMIA
272 reports
5
THROMBOCYTOPENIA
259 reports
6
NAUSEA
258 reports
7
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME
254 reports
8
DEATH
244 reports
9
DISEASE PROGRESSION
244 reports
10
MALIGNANT NEOPLASM PROGRESSION
236 reports